Picture Berlin Partner Voices Peter Seeberger Chemistry Transformation 650x100px
Collaboration › Details

Exscientia–Morgan Stanley: investor conference, 202309 supply service Exscientia to present at Morgan Stanley Annual Global Healthcare Conference 2023


Period Period 2023-09-12
Region Region Boston, MA
  Country United States (USA)
Organisations Partner, 1st Exscientia plc (Nasdaq: EXAI)
  Group Exscientia (Group)
  Partner, 2nd Morgan Stanley & Co. LLC
Products Product Morgan Stanley Global Healthcare Conference 2023 New York
  Product 2 AI-based drug discovery / AI-based drug development
Persons Person Sherman, Sara (Exscientia 202109 Investor Relations)
  Person 2 Stohlmann, Oliver (Exscientia 202306 Media Relations)

Exscientia plc. (8/31/23). "Press Release: Exscientia to Present at Upcoming Investor Conferences in September". Oxford.

Exscientia plc (Nasdaq: EXAI) today announced that members of Exscientia management will participate in the following upcoming investor conferences in September:

> 2023 Wells Fargo Healthcare Conference. Fireside chat on Thursday, September 7, 2023, at 3:45 p.m. EDT (8:45 p.m. BST) in Boston, Massachusetts

> Morgan Stanley Global Healthcare Conference 2023. Formal presentation on Tuesday, September 12, 2023, at 8:10 a.m. EDT (1:10 p.m. BST) in New York, NY

Live webcasts will be available on the Company’s website, under the “Investors & Media” section at Archived replays of the webcasts will be available for approximately 30 days following the presentation.

About Exscientia

Exscientia is an AI-driven precision medicine company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our internal pipeline is focused on leveraging our precision medicine platform in oncology, while our partnered pipeline broadens our approach to other therapeutic areas. By pioneering a new approach to medicine creation, we believe the best ideas of science can rapidly become the best medicines for patients.

For more information visit us on or follow us on Twitter @exscientiaAI.

Investor Relations Contact:
Sara Sherman

Media Contact:
Oliver Stohlmann

Record changed: 2023-09-09


Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x200px

More documents for Exscientia (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x300px

» top